Circulating ficolin-2 and ficolin-3 in normal pregnancy and pre-eclampsia

Clinical and Experimental Immunology

Volumn 169, Issue 1, 2012, Pages 49-56

  Halmos, A ^a   Rigo J ^a   Szijarto J ^a   Fust G ^b   Prohaszka Z ^b,c   Molvarec, A ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Complement; Ficolin; Pre eclampsia; Pregnancy; SFlt 1

Indexed keywords

ANGIOGENIC PROTEIN; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4D; COMPLEMENT COMPONENT C5B; COMPLEMENT COMPONENT SC5B9; CREATININE; FIBRONECTIN; FICOLIN; FICOLIN 2; FICOLIN 3; LACTATE DEHYDROGENASE; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; THIRD TRIMESTER PREGNANCY; TROPHOBLAST; UREA NITROGEN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CASE-CONTROL STUDIES; COMPLEMENT ACTIVATION; CREATININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRONECTINS; GLYCOPROTEINS; HUMANS; LECTINS; OXIDATIVE STRESS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; TROPHOBLASTS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VON WILLEBRAND FACTOR;

EID: 84861748066     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2012.04590.x     Document Type: Article

References (56)

1. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180:499-506.
2. Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol Aspects Med 2007; 28:192-209.
3. Derzsy Z, Prohaszka Z, Rigo J Jr, Fust G, Molvarec A. Activation of the complement system in normal pregnancy and preeclampsia. Mol Immunol 2010; 47:1500-6.
4. Csuka D, Molvarec A, Derzsy Z etal. Functional analysis of the mannose-binding lectin complement pathway in normal pregnancy and preeclampsia. J Reprod Immunol 2010; 87:90-6.
5. Endo Y, Matsushita M, Fujita T. Role of ficolin in innate immunity and its molecular basis. Immunobiology 2007; 212:371-9.
6. Endo Y, Matsushita M, Fujita T. The role of ficolins in the lectin pathway of innate immunity. Int J Biochem Cell Biol 2011; 43:705-12.
7. Matsushita M. Ficolins: complement-activating lectins involved in innate immunity. J Innate Immun 2009; 2:24-32.
8. Lazar L, Nagy B, Ban Z, Nagy GR, Papp Z. Presence of cell-free fetal DNA in plasma of women with ectopic pregnancies. Clin Chem 2006; 52:1599-601.
9. Feinberg BB, Jack RM, Mok SC, Anderson DJ. Low erythrocyte complement receptor type 1 (CR1, CD35) expression in preeclamptic gestations. Am J Reprod Immunol 2005; 54:352-7.
10. Feinberg BB. Preeclampsia: the death of Goliath. Am J Reprod Immunol 2006; 55:84-98.
11. van de Geijn FE, Roos A, de Man YA etal. Mannose-binding lectin levels during pregnancy: a longitudinal study. Hum Reprod 2007; 22:362-71.
12. Sziller I, Babula O, Hupuczi P etal. Mannose-binding lectin (MBL) codon 54 gene polymorphism protects against development of pre-eclampsia, HELLP syndrome and pre-eclampsia-associated intrauterine growth restriction. Mol Hum Reprod 2007; 13:281-5.
13. Than NG, Romero R, Erez O etal. A role for mannose-binding lectin, a component of the innate immune system in pre-eclampsia. Am J Reprod Immunol 2008; 60:333-45.
14. Celik N, Ozan H. Maternal serum mannose-binding lectin in severe preeclampsia. Clin Exp Obstet Gynecol 2008; 35:179-82.
15. Wang CC, Yim KW, Poon TC etal. Innate immune response by ficolin binding in apoptotic placenta is associated with the clinical syndrome of preeclampsia. Clin Chem 2007; 53:42-52.
16. van de Geijn FE, Dolhain RJ, van Rijs W, Hazes JM, de Groot CJ. Mannose-binding lectin genotypes and pre-eclampsia: a case-control study. Hum Immunol 2007; 68:888-93.
17. Lynch AM, Murphy JR, Byers T etal. Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia. Am J Obstet Gynecol 2008; 198:385 e1-9.
18. Lynch AM, Murphy JR, Gibbs RS etal. The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia. BJOG 2010; 117:456-62.
19. Matsushita M, Endo Y, Taira S etal. A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin. J Biol Chem 1996; 271:2448-54.
20. Taira S, Kodama N, Matsushita M, Fujita T. Opsonic function and concentration of human serum ficolin/P35. Fukushima J Med Sci 2000; 46:13-23.
21. Kuraya M, Ming Z, Liu X, Matsushita M, Fujita T. Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation. Immunobiology 2005; 209:689-97.
22. Jensen ML, Honore C, Hummelshoj T, Hansen BE, Madsen HO, Garred P. Ficolin-2 recognizes DNA and participates in the clearance of dying host cells. Mol Immunol 2007; 44:856-65.
23. Honore C, Hummelshoj T, Hansen BE, Madsen HO, Eggleton P, Garred P. The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells. Arthritis Rheum 2007; 56:1598-607.
24. Nelson DM. Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast. Placenta 1996; 17:387-91.
25. Leung DN, Smith SC, To KF, Sahota DS, Baker PN. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2001; 184:1249-50.
26. Jones CJ, Fox H. An ultrastructural and ultrahistochemical study of the human placenta in maternal pre-eclampsia. Placenta 1980; 1:61-76.
27. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008; 51:970-5.
28. Lo YM, Leung TN, Tein MS etal. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999; 45:184-8.
29. Johansen M, Redman CW, Wilkins T, Sargent IL. Trophoblast deportation in human pregnancy-its relevance for pre-eclampsia. Placenta 1999; 20:531-9.
30. Redman CW, Sargent IL. Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta 2008; 29 (Suppl. A):S73-7.
31. Guller S. Role of the syncytium in placenta-mediated complications of preeclampsia. Thromb Res 2009; 124:389-92.
32. Guller S, Tang Z, Ma YY, Di Santo S, Sager R, Schneider H. Protein composition of microparticles shed from human placenta during placental perfusion: potential role in angiogenesis and fibrinolysis in preeclampsia. Placenta 2011; 32:63-9.
33. Rajakumar A, Cerdeira AS, Rana S etal. Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia. Hypertension 2012; 59:256-64.
34. Maynard SE, Min JY, Merchan J etal. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111:649-58.
35. Levine RJ, Maynard SE, Qian C etal. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350:672-83.
36. Molvarec A, Szarka A, Walentin S, Szucs E, Nagy B, Rigo J Jr. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia. Hypertens Res 2010; 33:892-8.
37. Roos A, Rastaldi MP, Calvaresi N etal. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 2006; 17:1724-34.
38. Atkinson AP, Cedzynski M, Szemraj J etal. L-ficolin in children with recurrent respiratory infections. Clin Exp Immunol 2004; 138:517-20.
39. Cedzynski M, Atkinson AP, St Swierzko A etal. L-ficolin (ficolin-2) insufficiency is associated with combined allergic and infectious respiratory disease in children. Mol Immunol 2009; 47:415-9.
40. Kilpatrick DC, Chalmers JD, MacDonald SL etal. Stable bronchiectasis is associated with low serum L-ficolin concentrations. Clin Respir J 2009; 3:29-33.
41. Swierzko AS, Atkinson AP, Cedzynski M etal. Two factors of the lectin pathway of complement, l-ficolin and mannan-binding lectin, and their associations with prematurity, low birthweight and infections in a large cohort of Polish neonates. Mol Immunol 2009; 46:551-8.
42. Svendsen CB, Hummelshoj T, Munthe-Fog L etal. Ficolins and mannose-binding lectin in Danish patients with sarcoidosis. Respir Med 2008; 102:1237-42.
43. Schlapbach LJ, Aebi C, Hansen AG, Hirt A, Jensenius JC, Ammann RA. H-ficolin serum concentration and susceptibility to fever and neutropenia in paediatric cancer patients. Clin Exp Immunol 2009; 157:83-9.
44. Schlapbach LJ, Mattmann M, Thiel S etal. Differential role of the lectin pathway of complement activation in susceptibility to neonatal sepsis. Clin Infect Dis 2010; 51:153-62.
45. Fust G, Munthe-Fog L, Illes Z etal. Low ficolin-3 levels in early follow-up serum samples are associated with the severity and unfavorable outcome of acute ischemic stroke. J Neuroinflammation 2011; 8:185.
46. Hummelshoj T, Munthe-Fog L, Madsen HO, Fujita T, Matsushita M, Garred P. Polymorphisms in the FCN2 gene determine serum variation and function of ficolin-2. Hum Mol Genet 2005; 14:1651-8.
47. Cedzynski M, Nuytinck L, Atkinson AP etal. Extremes of L-ficolin concentration in children with recurrent infections are associated with single nucleotide polymorphisms in the FCN2 gene. Clin Exp Immunol 2007; 150:99-104.
48. Munthe-Fog L, Hummelshoj T, Ma YJ etal. Characterization of a polymorphism in the coding sequence of FCN3 resulting in a ficolin-3 (Hakata antigen) deficiency state. Mol Immunol 2008; 45:2660-6.
49. Messias-Reason IJ, Schafranski MD, Kremsner PG, Kun JF. Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease. Clin Exp Immunol 2009; 157:395-9.
50. de Rooij BJ, van Hoek B, ten Hove WR etal. Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation. Hepatology 2010; 52:1100-10.
51. de Rooij BJ, van der Beek MT, van Hoek B etal. Mannose-binding lectin and ficolin-2 gene polymorphisms predispose to cytomegalovirus (re)infection after orthotopic liver transplantation. J Hepatol 2011; 55:800-7.
52. Munthe-Fog L, Hummelshoj T, Honore C, Madsen HO, Permin H, Garred P. Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency. N Engl J Med 2009; 360:2637-44.
53. Molvarec A, Prohaszka Z, Nagy B etal. Association of increased serum heat shock protein 70 and C-reactive protein concentrations and decreased serum alpha(2)-HS glycoprotein concentration with the syndrome of hemolysis, elevated liver enzymes, and low platelet count. J Reprod Immunol 2007; 73:172-9.
54. Molvarec A, Jermendy A, Nagy B etal. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction. Clin Chim Acta 2008; 392:52-7.
55. Molvarec A, Rigo J Jr, Lazar L etal. Increased serum heat-shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia. Cell Stress Chaperones 2009; 14:151-9.
56. Rosta K, Molvarec A, Enzsoly A etal. Association of extracellular superoxide dismutase (SOD3) Ala40Thr gene polymorphism with pre-eclampsia complicated by severe fetal growth restriction. Eur J Obstet Gynecol Reprod Biol 2009; 142:134-8.